Key Genes of the Immune System and Predisposition to Acquired Hemophilia A

Acquired hemophilia A (AHA) is a rare bleeding disorder caused by the presence of autoantibodies against factor VIII (FVIII). As with other autoimmune diseases, its etiology is complex and its genetic basis is unknown. The aim of this study was to identify the immunogenetic background that predispos...

ver descrição completa

Detalhes bibliográficos
Autores: Pardos-Gea, Josep|||0000-0002-3725-6849, Martin-Fernandez, Laura|||0000-0002-8909-508X, Closa, Laia|||0000-0001-8007-5077, Ferrero, Ainara, Marzo, Cristina|||0000-0001-6085-2158, Rubio Rivas, Manuel|||0000-0002-9548-1374, Mitjavila, Francesca, González-Porras, José Ramón, Bastida, J.M.|||0000-0002-8007-3909, Mateo, Jose|||0000-0002-4227-3256, Carrasco Exposito, Marina|||0000-0001-8301-8000, Bernardo Gutiérrez, Ángel|||0000-0001-9711-8037, Astigarraga, Itziar|||0000-0002-5012-0137, Aguinaco, Reyes, Corrales Insa, Irene|||0000-0002-0647-0340, García-Martinez, Iris|||0000-0001-6656-3322, Vidal, Francisco|||0000-0001-8089-4945
Tipo de documento: artigo
Data de publicação:2023
País:España
Recursos:Universitat Autònoma de Barcelona
Repositório:Dipòsit Digital de Documents de la UAB
Idioma:inglês
OAI Identifier:oai:ddd.uab.cat:291450
Acesso em linha:https://ddd.uab.cat/record/291450
https://dx.doi.org/urn:doi:10.3390/ijms242216372
Access Level:Acceso aberto
Palavra-chave:Acquired hemophilia A
Autoantibodies
Genetic predisposition to disease
Immunogenetics
Next-generation sequencing
Rare bleeding disorders
Descrição
Resumo:Acquired hemophilia A (AHA) is a rare bleeding disorder caused by the presence of autoantibodies against factor VIII (FVIII). As with other autoimmune diseases, its etiology is complex and its genetic basis is unknown. The aim of this study was to identify the immunogenetic background that predisposes individuals to AHA. HLA and KIR gene clusters, as well as KLRK1, were sequenced using next-generation sequencing in 49 AHA patients. Associations between candidate genes involved in innate and adaptive immune responses and AHA were addressed by comparing the alleles, genotypes, haplotypes, and gene frequencies in the AHA cohort with those in the donors' samples or Spanish population cohort. Two genes of the HLA cluster, as well as rs1049174 in KLRK1, which tags the natural killer (NK) cytotoxic activity haplotype, were found to be linked to AHA. Specifically, A*03:01 (p = 0.024; odds ratio (OR) = 0.26[0.06-0.85]) and DRB1*13:03 (p = 6.8 × 10 3, OR = 7.56[1.64-51.40]), as well as rs1049174 (p = 0.012), were significantly associated with AHA. In addition, two AHA patients were found to carry one copy each of the low-frequency allele DQB1*03:09 (n = 2, 2.04%), which was completely absent in the donors. To the best of our knowledge, this is the first time that the involvement of these specific alleles in the predisposition to AHA has been proposed. Further molecular and functional studies will be needed to unravel their specific contributions. We believe our findings expand the current knowledge on the genetic factors involved in susceptibility to AHA, which will contribute to improving the diagnosis and prognosis of AHA patients.